Per the notice below, the United States Food and Drug Administration (FDA) has issued a glossary on digital health and artificial intelligence (AI).

FDA Publishes Digital Health and Artificial Intelligence Glossary

Today, the U.S. Food and Drug Administration (FDA) published a digital health and artificial intelligence glossary as an educational resource to help support consistent use of digital health and artificial intelligence terminology by the FDA and interested parties (such as industry, digital health developers, academia, health care professionals, and patients).

View the glossary

The FDA plans to update the glossary as appropriate.

Questions or Feedback?

The FDA requests that you send your input and questions on the digital health and artificial intelligence glossary by e-mail to digitalhealth@fda.hhs.gov, with “Attn: DH/AI Glossary,” in the subject line.